Variant report

Variant	rs7304815
Chromosome Location	chr12:50377934-50377935
allele	A/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr12:50377547..50379840-chr12:50410824..50414125,3	K562	blood:
2	chr12:50376082..50378233-chr12:50414724..50416440,2	K562	blood:
3	chr12:50377494..50379997-chr12:50383647..50387031,3	K562	blood:

Variant related genes	Relation type
ENSG00000161800	Chromatin interaction

Extended variants
information (count: 27 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:16)

rs_ID	r²[population]
rs17119741	1.00[EUR][1000 genomes]
rs17124532	1.00[EUR][1000 genomes]
rs2232209	1.00[EUR][1000 genomes]
rs297903	1.00[EUR][1000 genomes]
rs297904	1.00[EUR][1000 genomes]
rs297908	1.00[EUR][1000 genomes]
rs297912	1.00[EUR][1000 genomes]
rs297915	1.00[EUR][1000 genomes]
rs364895	1.00[EUR][1000 genomes]
rs440721	1.00[EUR][1000 genomes]
rs487193	1.00[EUR][1000 genomes]
rs55853170	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs57423894	1.00[EUR][1000 genomes]
rs726044	1.00[EUR][1000 genomes]
rs74089213	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs74091125	1.00[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:11 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1045327	chr12:49975040-50551375	Strong transcription Weak transcription Enhancers Genic enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	170 gene(s)	inside rSNPs	diseases
2	nsv541490	chr12:49975040-50551375	Weak transcription Transcr. at gene 5' and 3' Enhancers Genic enhancers Active TSS Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	170 gene(s)	inside rSNPs	diseases
3	nsv522972	chr12:50196394-50410831	Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	49 gene(s)	inside rSNPs	diseases
4	nsv530671	chr12:50233858-50708991	Flanking Active TSS Active TSS Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	117 gene(s)	inside rSNPs	diseases
5	nsv832407	chr12:50243268-50412236	Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	33 gene(s)	inside rSNPs	diseases
6	nsv558835	chr12:50275137-50433234	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases
7	nsv899072	chr12:50326176-50379667	Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
8	esv1827130	chr12:50349765-50379667	Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	14 gene(s)	inside rSNPs	diseases
9	nsv469374	chr12:50349765-50467769	Weak transcription Flanking Bivalent TSS/Enh Enhancers Strong transcription Bivalent Enhancer Active TSS Bivalent/Poised TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
10	nsv469375	chr12:50349765-50467769	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
11	nsv558837	chr12:50349765-50467769	Bivalent/Poised TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:104 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:50362600-50385800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr12:50367000-50378000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr12:50367400-50401200	Weak transcription	Gastric	stomach
4	chr12:50369200-50381600	Weak transcription	Sigmoid Colon	Sigmoid Colon
5	chr12:50369600-50379200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
6	chr12:50369600-50418200	Weak transcription	Colonic Mucosa	Colon
7	chr12:50372200-50378200	Weak transcription	Pancreatic Islets	Pancreatic Islet
8	chr12:50372400-50404800	Weak transcription	Spleen	Spleen
9	chr12:50373400-50378400	Weak transcription	H1 Cell Line	embryonic stem cell
10	chr12:50373600-50378200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
11	chr12:50373600-50381600	Weak transcription	H9 Cell Line	embryonic stem cell
12	chr12:50373800-50378200	Weak transcription	HUES6 Cell Line	embryonic stem cell
13	chr12:50373800-50378600	Weak transcription	HUES48 Cell Line	embryonic stem cell
14	chr12:50373800-50379600	Weak transcription	GM12878-XiMat	blood
15	chr12:50374200-50379000	Enhancers	K562	blood
16	chr12:50374600-50378200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
17	chr12:50374600-50379000	Enhancers	Fetal Kidney	kidney
18	chr12:50374800-50381600	Weak transcription	HUES64 Cell Line	embryonic stem cell
19	chr12:50375000-50378000	Weak transcription	Fetal Brain Female	brain
20	chr12:50375000-50379400	Weak transcription	Hela-S3	cervix
21	chr12:50375200-50378400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
22	chr12:50375200-50379600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr12:50375200-50385400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr12:50375600-50378600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr12:50375800-50378400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr12:50375800-50379000	Enhancers	Fetal Stomach	stomach
27	chr12:50375800-50380800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr12:50376000-50378000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
29	chr12:50376000-50378600	Enhancers	Primary hematopoietic stem cells short term culture	blood
30	chr12:50376000-50378600	Enhancers	Fetal Lung	lung
31	chr12:50376000-50378800	Enhancers	Brain Substantia Nigra	brain
32	chr12:50376000-50378800	Enhancers	Placenta	Placenta
33	chr12:50376000-50379200	Enhancers	Fetal Intestine Large	intestine
34	chr12:50376000-50380200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr12:50376000-50380200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr12:50376200-50378800	Enhancers	NHLF	lung
37	chr12:50376200-50379000	Enhancers	Rectal Smooth Muscle	rectum
38	chr12:50376200-50380000	Enhancers	NHDF-Ad	bronchial
39	chr12:50376200-50383800	Weak transcription	Primary T cells from cord blood	blood
40	chr12:50376400-50378200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr12:50376400-50378800	Enhancers	HSMM	muscle
42	chr12:50376400-50385800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
43	chr12:50376600-50378600	Enhancers	Brain Cingulate Gyrus	brain
44	chr12:50376600-50379200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr12:50376600-50380400	Weak transcription	Primary neutrophils fromperipheralblood	blood
46	chr12:50376800-50380000	Enhancers	Cortex derived primary cultured neurospheres	brain
47	chr12:50376800-50384000	Weak transcription	Primary B cells from cord blood	blood
48	chr12:50377000-50378200	Enhancers	Fetal Brain Male	brain
49	chr12:50377200-50378000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr12:50377200-50378400	Enhancers	Brain Angular Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links